IU202 - Meaningful Innovation: Today and in the Future

Abstract: Explore Cochlear’s latest hearing implant technologies shaping the future of patient care. This session will spotlight the Nucleus® Nexa System, Cochlear’s latest innovation. We’ll also explore advances in bone conduction solutions, including the Baha® 7 Sound Processor and Osia® System, that improve connectivity, expand access, and deliver superior outcomes for patients with conductive or mixed hearing loss. We’ll introduce Real-World Evidence (RWE), the world’s largest hearing implant database and explore how it will enhance future innovation. Discover how these innovations are driving possibilities for a lifetime of better hearing.

Summary: This session will begin by highlighting the Nucleus® Nexa Cochlear Implant System, Cochlear’s latest innovation. Designed to optimize hearing performance, Nexa introduces next-generation implant technology and power management strategies that support enhanced sound quality, improved battery efficiency, and more possibilities for a lifetime of better hearing.

Next, we’ll explore Cochlear’s bone conduction portfolio, which includes the Baha® 7 Sound Processor and the Osia® System. These solutions are designed for individuals with conductive or mixed hearing loss, as well as single-sided deafness. The Baha 7 offers improved wireless connectivity, intuitive controls, and a discreet design that enhances patient comfort and usability. The Osia System, powered by unique active piezoelectric technology, delivers powerful and consistent sound transmission, making it the world’s most chosen bone conduction system. These innovations aim to provide patients with optimal hearing experiences.

Finally, the session will introduce Real-World Evidence (RWE), a transformative approach to innovation grounded in data. Cochlear maintains the world’s largest hearing implant database, which captures outcomes, usage patterns, and patient-reported experiences across a global population. By leveraging this rich dataset, Cochlear can identify trends, validate clinical effectiveness, and guide future product development. RWE not only supports evidence-based decision-making for clinicians but also ensures that Cochlear’s technologies continue to evolve in alignment with real-world patient needs.

Attendees will gain insight into how these technologies are redefining standards in hearing care, offering smarter, more connected, and more personalized solutions. This session will provide valuable perspectives on the future of hearing implants and the role of data in driving continuous improvement.

Brief Summary of Clinical Takeaways: The clinical takeaway for this session is for attendees to gain insight into how new innovations in implantable technologies are redefining standards in hearing care to offer more personalized solutions. Attendees will gain perspectives on the future of hearing implants and the role of data in driving continuous improvement.

Assumptions: n/a